Latest news with #EvercoreISI
Globe and Mail
2 days ago
- Business
- Globe and Mail
DELL Stock Slides despite Praise from Wall Street
Yesterday, Dell Technologies (DELL) reported strong revenue results and provided a positive outlook, which suggests that the company is handling tariff issues effectively and increasing its share of the AI market. However, shares of the tech company are down at the time of writing. This is despite also receiving analyst praise for its performance and ability to benefit from increased AI spending in a tough economic environment. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Indeed, five-star Evercore ISI analyst Amit Daryanani, who rates Dell as Outperform with a $140 price target, said that Dell managed to limit the impact of tariffs and kept prices stable, unlike some of its competitors. He also pointed out that Dell's AI server business is growing fast, as its backlog increased by $5 billion from the previous quarter to $14.4 billion. As a result, he believes that customers are willing to pay more for Dell's strong supply chain and better execution, which should help the company gain market share even as a premium provider. Separately, five-star Wells Fargo analyst Aaron Rakers also kept an Overweight rating and a $150 price target on the stock. He said that Dell's results and outlook support the idea that the company is well-positioned for Nvidia's (NVDA) upcoming Blackwell chip cycle. Rakers also noted that Dell is handling its supply chain well, benefiting from a wave of commercial PC upgrades, and generating healthy free cash flow, which it is using to give money back to shareholders. Is DELL Stock a Buy? Overall, analysts have a Strong Buy consensus rating on DELL stock based on 10 Buys, one Hold, and zero Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average DELL price target of $134.55 per share implies 20% upside potential.
Yahoo
2 days ago
- Business
- Yahoo
Zscaler price target raised to $290 from $245 at Evercore ISI
Evercore ISI raised the firm's price target on Zscaler (ZS) to $290 from $245 and keeps an Outperform rating on the shares. Zscaler delivered 'a stellar F3Q,' surpassing expectations across key metrics and reinforcing confidence in the new go-to-market strategy, the analyst tells investors. However, caution is advised as FY26 consensus estimates 'seem overly optimistic for now,' adds the analyst, whose initial FY26 revenue growth estimate is set at 18.5%, below the consensus of 20.2%. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on ZS: Disclaimer & DisclosureReport an Issue Zscaler price target raised to $300 from $270 at TD Cowen Zscaler price target raised to $290 from $275 at Cantor Fitzgerald Zscaler price target raised to $300 from $240 at Wedbush Zscaler price target raised to $304 from $288 at RBC Capital Zscaler price target raised to $290 from $250 at Oppenheimer
Yahoo
2 days ago
- Business
- Yahoo
UiPath price target raised to $15 from $11 at Evercore ISI
Evercore ISI raised the firm's price target on UiPath (PATH) to $15 from $11 and keeps an In Line rating on the shares following 'encouraging' fiscal Q1 results. Revenue and operating margin exceeded expectations thanks to the company's business model transformation and operational efficiencies, notes the analyst. A 'solid start to FY26,' coupled with strategic moves in partnerships and operational efficiency, 'sets a positive tone,' though consistent outperformance and further agentic strategy validation will be key to shifting investor sentiment, the analyst added. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on PATH: Disclaimer & DisclosureReport an Issue UiPath price target raised to $15 from $13 at RBC Capital UiPath: Balancing Optimism and Caution Amid Economic Uncertainty UiPath's Growth Challenges Amid Strong Revenue Performance: Analyst Maintains Hold Rating UiPath's Promising AI Growth and Market Challenges Lead to Hold Rating UiPath price target raised to $14 from $12 at Barclays Sign in to access your portfolio
Business Insider
2 days ago
- Business
- Business Insider
Evercore ISI Sticks to Its Buy Rating for Intellia Therapeutics (NTLA)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) yesterday and set a price target of $48.00. The company's shares closed yesterday at $7.45. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Bayko is a 4-star analyst with an average return of 5.9% and a 40.98% success rate. Bayko covers the Healthcare sector, focusing on stocks such as Altimmune, Vertex Pharmaceuticals, and Intellia Therapeutics. In addition to Evercore ISI, Intellia Therapeutics also received a Buy from JonesTrading's Debanjana Chatterjee in a report issued today. However, yesterday, J.P. Morgan maintained a Hold rating on Intellia Therapeutics (NASDAQ: NTLA). The company has a one-year high of $28.18 and a one-year low of $5.90. Currently, Intellia Therapeutics has an average volume of 3.83M.
Business Insider
2 days ago
- Business
- Business Insider
Evercore ISI Sticks to Its Hold Rating for Arch Capital Group (ACGL)
In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Arch Capital Group (ACGL – Research Report), with a price target of $104.00. Protect Your Portfolio Against Market Uncertainty According to TipRanks, Motemaden is a 5-star analyst with an average return of 11.2% and a 70.23% success rate. Motemaden covers the Financial sector, focusing on stocks such as Chubb, Arthur J Gallagher & Co, and Arch Capital Group. In addition to Evercore ISI, Arch Capital Group also received a Hold from Barclays's Alex Scott in a report issued yesterday. However, on the same day, JMP Securities reiterated a Buy rating on Arch Capital Group (NASDAQ: ACGL). Based on Arch Capital Group's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $4.51 billion and a net profit of $935 million. In comparison, last year the company earned a revenue of $3.87 billion and had a net profit of $2.33 billion Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ACGL in relation to earlier this year. Most recently, in March 2025, Louis Petrillo, the Subsid. Officer of ACGL sold 21,000.00 shares for a total of $1,927,262.00.
